Genetic renal abnormalities

Medicine

Volumn 35, Issue 7, 2007, Pages 386-392

  Maxwell, A Peter ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Alport's syndrome; microscopic haematuria; polycystic kidneys; renal genetics; thin basement membrane nephropathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM; CIPROFLOXACIN; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA5; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; PLACEBO; POLYCYSTIN 1; POLYCYSTIN 2; POTASSIUM; SOMATOSTATIN; TOLVAPTAN; UNCLASSIFIED DRUG;

ABDOMINAL RADIOGRAPHY; ALPORT SYNDROME; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BRAIN ARTERY ANEURYSM; CHROMOSOME 16P; CHROMOSOME 4Q; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES INSIPIDUS; DIALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROLYTE DISTURBANCE; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; GLOMERULUS BASEMENT MEMBRANE; HEMATURIA; HUMAN; HYPERCALCIURIA; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INFECTION; KIDNEY CALCIFICATION; KIDNEY CYST; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; MEDULLARY SPONGE KIDNEY; NEPHROLITHIASIS; NEPHRONOPHTHISIS; NONHUMAN; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PHENOTYPE; POLYURIA; PREECLAMPSIA; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SKIN BIOPSY; TUBEROUS SCLEROSIS; URINARY TRACT INFECTION; VON HIPPEL LINDAU DISEASE;

EID: 34250721164     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2007.04.004     Document Type: Review

References (19)

1. UK Renal Registry Report, 2005. Available at: www.renalreg.com
2. United States Renal Data System, 2006. Available at: www.renal.org
3. Rotig A., and Niaudet P. Mitochondrial nephrology. In: DiMauro A., Hirano M., and Schon E.A. (Eds). Mitochondrial medicine (2006), Informa Healthcare, Abingdon
4. Kim W.Y., and Kaelin W.G. Role of VHL gene mutation in human cancer. J Clin Oncol 22 (2004) 4991-5004
5. Woolf A.S. Renal hypoplasia and dysplasia: starting to put the puzzle together. J Am Soc Nephrol 17 (2006) 2647-2649
6. Mak R.H., and Kuo H.J. Primary ureteral reflux: Emerging insights from molecular and genetic studies. Curr Opin Pediatr 15 (2003) 181-185
7. Ong A.C., and Wheatley D.N. Polycystic kidney disease-the ciliary connection. Lancet 361 (2003) 774-846
8. Ravine D., Gibson R.N., Walker R.G., Sheffield L.J., Kincaid-Smith P., and Danks D.M. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343 (1994) 824-827
9. Grantham J.J., Torres V.E., Chapman A.B., et al. Volume progression in polycystic kidney disease. N Engl J Med 354 (2006) 2122-2130
10. Hateboer N., v Dijk M.A., Bogdanova N., et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353 (1999) 103-107
11. Gibbs G.F., Huston III J., Qian Q., et al. Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int 65 (2004) 1621-1627
12. Levey A.S., Greene T., Beck G.J., et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol 10 (1999) 2426-2439
13. Rugggeneti P., Remuzzi A., Ondel P., et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 68 (2005) 206-216
14. Bennett W.M. V2 Receptor antagonists in cystic kidney diseases: an exciting step towards a practical treatment. J Am Soc Nephrol 16 (2005) 827-828
15. Dische F.E., Anderson V.E., Keane S.J., Taube D., Bewick M., and Parsons V. Incidence of thin membrane nephropathy: morphometric investigation of a population sample. J Clin Pathol 43 (1990) 457-460
16. Hudson B.G., Tryggvason K., Sundaramoorthy M., and Neilson E.G. Alport's syndrome, Goodpasture's syndrome and type IV collagen. N Engl J Med 348 (2003) 2543-2556
17. Tryggvason K., Patrakka J., and Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354 (2006) 1387-1401
18. Torra R., Tazon-Vega B., Ars E., and Ballarin J. Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. Nephrol Dial Transplant 19 (2004) 2429-2432
19. Kashtan C.E. Alport syndrome: is diagnosis only skin deep?. Kidney Int 55 (1999) 1575-1576